Cargando…

Potential Antimetastatic Effect of Timosaponin AIII against Human Osteosarcoma Cells through Regulating the Integrin/FAK/Cofilin Axis

Timosaponin AIII (TSAIII) is a steroidal saponin which demonstrates anti-tumour activities. However, the effect of TSAIII on human osteosarcoma cells remains largely unknown. In this study, we demonstrated that TSAIII exerted a significant inhibitory effect on the distribution of cytoskeletal F-acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Yi-Hsien, Hsu, Wen-Hung, Yang, Shun-Fa, Liu, Chung-Jung, Lu, Ko-Hsiu, Wang, Pei-Han, Lin, Renn-Chia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000016/ https://www.ncbi.nlm.nih.gov/pubmed/33799345 http://dx.doi.org/10.3390/ph14030260

Ejemplares similares

Synergistic anticancer effects of timosaponin AIII and ginsenosides in MG63 human osteosarcoma cells
por: Jung, Okkeun, et al.
Publicado: (2019)

The Potential Role of Timosaponin-AIII in Cancer Prevention and Treatment
por: Liu, Zhaowen, et al.
Publicado: (2023)

Blockage of Autophagy Increases Timosaponin AIII-Induced Apoptosis of Glioma Cells In Vitro and In Vivo
por: Lee, Chu-Che, et al.
Publicado: (2022)

Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
por: Lu, Lu, et al.
Publicado: (2018)

Ginsenoside Rg1 Drives Stimulations of Timosaponin AIII-Induced Anticancer Effects in Human Osteosarcoma Cells
por: Lee, Sang Yeol
Publicado: (2020)

Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo
por: Zhou, Zhong-yan, et al.
Publicado: (2019)

Comparison of the pharmacokinetics of timosaponin AIII, timosaponin BIII, and mangiferin extracted from crude and salt-processed Anemarrhenae Rhizoma by UPLC-MS/MS
por: Wang, XiaoTing, et al.
Publicado: (2023)

Timosaponin AIII inhibits melanoma cell migration by suppressing COX‐2 and in vivo tumor metastasis
por: Kim, Ki Mo, et al.
Publicado: (2016)

Timosaponin AIII Is Preferentially Cytotoxic to Tumor Cells through Inhibition of mTOR and Induction of ER Stress
por: King, Frank W., et al.
Publicado: (2009)

Rapid and Sensitive Determination of Timosaponin AIII in Rat Plasma by LC-MS/MS and Its Pharmacokinetic Application
por: Liu, Yanping, et al.
Publicado: (2013)

Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
por: Li, Xiaofeng, et al.
Publicado: (2022)

Functional Axis of PDE5/cGMP Mediates Timosaponin-AIII-Elicited Growth Suppression of Glioblastoma U87MG Cells
por: Liao, Ya-Fang, et al.
Publicado: (2023)

Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor
por: Cong, Yue, et al.
Publicado: (2016)

Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer
por: Zhang, Lijuan, et al.
Publicado: (2021)

Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Anemarrhena asphodeloides Bunge and its constituent timosaponin‐AIII induce cell cycle arrest and apoptosis in pancreatic cancer cells
por: MarElia, Catherine B., et al.
Publicado: (2018)

Timosaponin AIII Inhibits Migration and Invasion Abilities in Human Cervical Cancer Cells through Inactivation of p38 MAPK-Mediated uPA Expression In Vitro and In Vivo
por: Chien, Hung-Ju, et al.
Publicado: (2022)

Pharmacological Activity, Pharmacokinetics, and Toxicity of Timosaponin AIII, a Natural Product Isolated From Anemarrhena asphodeloides Bunge: A Review
por: Lin, Yan, et al.
Publicado: (2020)

Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells
por: Tsai, Chung-Hsin, et al.
Publicado: (2013)

Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways
por: Zhang, Minjie, et al.
Publicado: (2021)

Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation
por: Zhou, Cong, et al.
Publicado: (2023)

Tomatidine Represses Invasion and Migration of Human Osteosarcoma U2OS and HOS Cells by Suppression of Presenilin 1 and c-Raf–MEK–ERK Pathway
por: Hsieh, Min-Hong, et al.
Publicado: (2020)

Licochalcone A-Induced Apoptosis Through the Activation of p38MAPK Pathway Mediated Mitochondrial Pathways of Apoptosis in Human Osteosarcoma Cells In Vitro and In Vivo
por: Lin, Renn-Chia, et al.
Publicado: (2019)

Mitophagy Effects of Protodioscin on Human Osteosarcoma Cells by Inhibition of p38MAPK Targeting NIX/LC3 Axis
por: Huang, Chien-Feng, et al.
Publicado: (2023)

Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma
por: Lu, Ko-Hsiu, et al.
Publicado: (2019)

CLEFMA Activates the Extrinsic and Intrinsic Apoptotic Processes through JNK1/2 and p38 Pathways in Human Osteosarcoma Cells
por: Yang, Jia-Sin, et al.
Publicado: (2019)

Graphene-Induced Osteogenic Differentiation Is Mediated by the Integrin/FAK Axis
por: Xie, Han, et al.
Publicado: (2019)

Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2012)

Correction: Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2017)

Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets
por: Stipp, Christopher S.
Publicado: (2010)

Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways
por: Cheng, Hsin-Lin, et al.
Publicado: (2016)

GO-Y078, a Curcumin Analog, Induces Both Apoptotic Pathways in Human Osteosarcoma Cells via Activation of JNK and p38 Signaling
por: Lu, Peace Wun-Ang, et al.
Publicado: (2021)

Clutching at Guidance Cues: The Integrin–FAK Axis Steers Axon Outgrowth
por: Davis-Lunn, Mathew, et al.
Publicado: (2023)

HO-3867 Induces Apoptosis via the JNK Signaling Pathway in Human Osteosarcoma Cells
por: Lu, Peace Wun-Ang, et al.
Publicado: (2022)

Apoptotic effect and cell arrest of deoxyshikonin in human osteosarcoma cells through the p38 pathway
por: Hsieh, Ming‐Chang, et al.
Publicado: (2023)

Mitochondrial Apoptosis and FAK Signaling Disruption by a Novel Histone Deacetylase Inhibitor, HTPB, in Antitumor and Antimetastatic Mouse Models
por: Shieh, Jiunn-Min, et al.
Publicado: (2012)

Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo
por: Ho, Mao-Lin, et al.
Publicado: (2011)

Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-κB and AP-1 Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2012)

Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy
por: Xu, B, et al.
Publicado: (2017)

Corrigendum to “Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-κB and AP-1 Activity”
por: Yeh, Chao-Bin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r2pmc38akbr9d77dot7qr2mklg